New from NICE

NICE recommends dimethyl fumarate (Tecfidera) as an option for treating adults with active RRMS provided they do not have highly active or rapidly evolving severe disease, as long as the manufacturer adheres to the agreed confidential patient access scheme.

New from NICE

Add yours ↓
Web design and marketing agency Leamington Spa